Yao, Yihong,Jallal, Bahija,Cibotti, Ricardo,Coyle, Anthony,Kiener, Peter
申请号：
AU2014200128
公开号：
AU2014200128A1
申请日:
2014.01.09
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
#$%^&*AU2014200128A120140130.pdf#####ABSTRACT The present invention encompasses type-I IFN and IFNa-induced PD marker expression profiles, kits, and methods for identifying such IFNa-induced PD marker 5 expression profiles. The type-I IFN and IFNa-induced PD marker expression profiles may also be used in, for example, methods of treating patients having a type-I IFN or IFNamediated disorder, methods of monitoring disease progression of patients receiving treatment with a therapeutic agent that binds to and modulates IFNa activity, identifying patients as candidates to receive a therapeutic that binds to and neutralizes IFNc activity, and in 10 diagnosing or providing a prognosis to patients having IFNa-induced disorders.
